hfpef semaglutide Poll: Do you think we'll see new FDA approval for semaglutide, specifically or Heart Failure and/or CKD, in 2025? 💊 This post highlights primary takeaways from 2 major trials from the past ~ STEP HFpEF Sub Studies Whiteboard

GLP-1-derived nonapeptide GLP-1(28-36) amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice

Tirzepatide often produces faster results, while Semaglutide provides steady weight loss

2) Oral administration of semaglutide led to a notable reduction in levels of HbA1c in test subjects diagnosed with type 2 diabetes 3) After 56 weeks of treatment, a 1.0 mg dose of semaglutide was successful in reducing body weight and improving glycemic control

instead, they arise spontaneously during cell division (similar to cancer mutations)

These symptoms are generally mild to moderate in severity and tend to diminish over time